Swedbank’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Swedbank's JAZZ Position: Q3 2026 in Review
Swedbank increased its Jazz Pharmaceuticals (JAZZ) stake by 2.8% in Q3 2026, buying an estimated $6.65M and bringing the position to 994,992 shares worth $230M. The position accounts for 0.2% of the portfolio, ranked #91.
Swedbank first reported a position in JAZZ in Q1 2021 and has held it in 22 quarters since. The position peaked at $233M in Q2 2026. 671 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Swedbank held 994,992 shares of Jazz Pharmaceuticals worth $230M as of Q3 2026.
- Swedbank bought 26,900 Jazz Pharmaceuticals shares in Q3 2026, an estimated $6.65M.
- Jazz Pharmaceuticals made up 0.2% of Swedbank's portfolio in Q3 2026, its #91 holding.
- Swedbank first reported a position in Jazz Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
- Swedbank's Jazz Pharmaceuticals position peaked at $233M in Q2 2026.
- 671 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Swedbank's 13F filing for Q3 2026, filed 27 Oct 2026.